AAPL311.74-4.49 (-1.42%) ▼|ABBV249.21+0.43 (+0.17%) ▲|ABT105.72+0.20 (+0.19%) ▲|ACN176.75-2.28 (-1.27%) ▼|ADBE257.46+0.20 (+0.08%) ▲|AMAT467.39-5.41 (-1.14%) ▼|AMD522.42+16.68 (+3.30%) ▲|AMGN390.72-2.46 (-0.62%) ▼|AMT175.63-0.10 (-0.06%) ▼|AMZN252.23-4.74 (-1.84%) ▼|AVGO364.57-3.99 (-1.08%) ▼|AXP322.83-3.28 (-1.00%) ▼|BA208.75-1.98 (-0.94%) ▼|BAC62.78+0.39 (+0.62%) ▲|BKNG172.74-7.57 (-4.20%) ▼|BLK1,079.84-15.54 (-1.42%) ▼|BMY64.62-0.07 (-0.11%) ▼|BNY163.39+0.54 (+0.33%) ▲|BRK-B509.18+3.35 (+0.66%) ▲|C138.16+1.42 (+1.03%) ▲|CAT817.45-5.04 (-0.61%) ▼|CL88.31-0.11 (-0.12%) ▼|CMCSA24.54-1.80 (-6.82%) ▼|COF212.55-1.41 (-0.66%) ▼|COP136.74+1.70 (+1.26%) ▲|COST899.91-10.27 (-1.13%) ▼|CRM247.38-1.74 (-0.70%) ▼|CSCO109.72+0.55 (+0.50%) ▲|CVS95.60-0.47 (-0.49%) ▼|CVX213.33+3.53 (+1.68%) ▲|DE674.23-6.51 (-0.96%) ▼|DHR205.10-0.13 (-0.06%) ▼|DIS104.63-0.43 (-0.41%) ▼|DUK120.02-1.22 (-1.01%) ▼|EMR151.40-0.76 (-0.50%) ▼|FDX309.89-4.24 (-1.35%) ▼|GD353.01-3.57 (-1.00%) ▼|GE325.34-9.57 (-2.86%) ▼|GEV953.97-17.35 (-1.79%) ▼|GILD145.95-0.69 (-0.47%) ▼|GM84.97-0.82 (-0.96%) ▼|GOOG329.06-6.32 (-1.88%) ▼|GOOGL331.34-7.02 (-2.07%) ▼|GS1,036.29-0.24 (-0.02%) ▼|HD310.83-2.87 (-0.91%) ▼|HON206.58-1.66 (-0.80%) ▼|IBM236.16+4.07 (+1.75%) ▲|INTC105.65+1.18 (+1.12%) ▲|INTU315.59-3.34 (-1.05%) ▼|ISRG351.85+1.69 (+0.48%) ▲|JNJ267.83-1.29 (-0.48%) ▼|JPM355.26+1.75 (+0.50%) ▲|KO87.87-0.50 (-0.56%) ▼|LIN466.03-2.35 (-0.50%) ▼|LLY1,126.41+2.50 (+0.22%) ▲|LMT525.97-10.18 (-1.90%) ▼|LOW198.81-2.00 (-0.99%) ▼|LRCX315.64-4.78 (-1.49%) ▼|MA569.75-1.15 (-0.20%) ▼|MCD255.40-0.41 (-0.16%) ▼|MDLZ61.95+0.32 (+0.52%) ▲|MDT92.48+0.09 (+0.10%) ▲|META653.30+39.82 (+6.49%) ▲|MMM164.81-2.72 (-1.62%) ▼|MO67.77-0.40 (-0.59%) ▼|MRK148.19-0.27 (-0.18%) ▼|MS216.40+0.16 (+0.07%) ▲|MSFT492.84-1.11 (-0.22%) ▼|MU1,022.62+22.36 (+2.24%) ▲|NEE82.89-0.95 (-1.13%) ▼|NFLX76.38-0.40 (-0.51%) ▼|NKE37.21-0.90 (-2.35%) ▼|NOW131.20-3.01 (-2.24%) ▼|NVDA224.25-1.48 (-0.66%) ▼|ORCL163.14+0.62 (+0.38%) ▲|PEP136.57-1.88 (-1.36%) ▼|PFE27.93+0.14 (+0.49%) ▲|PG142.94-2.64 (-1.81%) ▼|PLTR170.85+0.55 (+0.32%) ▲|PM185.24+0.51 (+0.27%) ▲|QCOM175.09+1.00 (+0.57%) ▲|RTX198.76-0.05 (-0.03%) ▼|SBUX100.83-1.19 (-1.16%) ▼|SCHW107.34+0.47 (+0.44%) ▲|SO88.21-0.78 (-0.88%) ▼|SPG206.38-3.25 (-1.55%) ▼|T25.10-0.51 (-1.97%) ▼|TMO606.16+3.14 (+0.52%) ▲|TMUS177.68-4.01 (-2.21%) ▼|TSLA368.98+0.82 (+0.22%) ▲|TXN261.45+2.53 (+0.98%) ▲|UBER71.71-1.42 (-1.94%) ▼|UNH392.19-8.65 (-2.16%) ▼|UNP284.77-3.68 (-1.28%) ▼|UPS99.34-1.15 (-1.14%) ▼|USB62.18-0.31 (-0.50%) ▼|V368.41-0.23 (-0.06%) ▼|VZ49.60-0.82 (-1.62%) ▼|WFC89.63+1.67 (+1.90%) ▲|WMT105.88-0.17 (-0.16%) ▼|XOM164.66+4.00 (+2.49%) ▲|AAPL311.74-4.49 (-1.42%) ▼|ABBV249.21+0.43 (+0.17%) ▲|ABT105.72+0.20 (+0.19%) ▲|ACN176.75-2.28 (-1.27%) ▼|ADBE257.46+0.20 (+0.08%) ▲|AMAT467.39-5.41 (-1.14%) ▼|AMD522.42+16.68 (+3.30%) ▲|AMGN390.72-2.46 (-0.62%) ▼|AMT175.63-0.10 (-0.06%) ▼|AMZN252.23-4.74 (-1.84%) ▼|AVGO364.57-3.99 (-1.08%) ▼|AXP322.83-3.28 (-1.00%) ▼|BA208.75-1.98 (-0.94%) ▼|BAC62.78+0.39 (+0.62%) ▲|BKNG172.74-7.57 (-4.20%) ▼|BLK1,079.84-15.54 (-1.42%) ▼|BMY64.62-0.07 (-0.11%) ▼|BNY163.39+0.54 (+0.33%) ▲|BRK-B509.18+3.35 (+0.66%) ▲|C138.16+1.42 (+1.03%) ▲|CAT817.45-5.04 (-0.61%) ▼|CL88.31-0.11 (-0.12%) ▼|CMCSA24.54-1.80 (-6.82%) ▼|COF212.55-1.41 (-0.66%) ▼|COP136.74+1.70 (+1.26%) ▲|COST899.91-10.27 (-1.13%) ▼|CRM247.38-1.74 (-0.70%) ▼|CSCO109.72+0.55 (+0.50%) ▲|CVS95.60-0.47 (-0.49%) ▼|CVX213.33+3.53 (+1.68%) ▲|DE674.23-6.51 (-0.96%) ▼|DHR205.10-0.13 (-0.06%) ▼|DIS104.63-0.43 (-0.41%) ▼|DUK120.02-1.22 (-1.01%) ▼|EMR151.40-0.76 (-0.50%) ▼|FDX309.89-4.24 (-1.35%) ▼|GD353.01-3.57 (-1.00%) ▼|GE325.34-9.57 (-2.86%) ▼|GEV953.97-17.35 (-1.79%) ▼|GILD145.95-0.69 (-0.47%) ▼|GM84.97-0.82 (-0.96%) ▼|GOOG329.06-6.32 (-1.88%) ▼|GOOGL331.34-7.02 (-2.07%) ▼|GS1,036.29-0.24 (-0.02%) ▼|HD310.83-2.87 (-0.91%) ▼|HON206.58-1.66 (-0.80%) ▼|IBM236.16+4.07 (+1.75%) ▲|INTC105.65+1.18 (+1.12%) ▲|INTU315.59-3.34 (-1.05%) ▼|ISRG351.85+1.69 (+0.48%) ▲|JNJ267.83-1.29 (-0.48%) ▼|JPM355.26+1.75 (+0.50%) ▲|KO87.87-0.50 (-0.56%) ▼|LIN466.03-2.35 (-0.50%) ▼|LLY1,126.41+2.50 (+0.22%) ▲|LMT525.97-10.18 (-1.90%) ▼|LOW198.81-2.00 (-0.99%) ▼|LRCX315.64-4.78 (-1.49%) ▼|MA569.75-1.15 (-0.20%) ▼|MCD255.40-0.41 (-0.16%) ▼|MDLZ61.95+0.32 (+0.52%) ▲|MDT92.48+0.09 (+0.10%) ▲|META653.30+39.82 (+6.49%) ▲|MMM164.81-2.72 (-1.62%) ▼|MO67.77-0.40 (-0.59%) ▼|MRK148.19-0.27 (-0.18%) ▼|MS216.40+0.16 (+0.07%) ▲|MSFT492.84-1.11 (-0.22%) ▼|MU1,022.62+22.36 (+2.24%) ▲|NEE82.89-0.95 (-1.13%) ▼|NFLX76.38-0.40 (-0.51%) ▼|NKE37.21-0.90 (-2.35%) ▼|NOW131.20-3.01 (-2.24%) ▼|NVDA224.25-1.48 (-0.66%) ▼|ORCL163.14+0.62 (+0.38%) ▲|PEP136.57-1.88 (-1.36%) ▼|PFE27.93+0.14 (+0.49%) ▲|PG142.94-2.64 (-1.81%) ▼|PLTR170.85+0.55 (+0.32%) ▲|PM185.24+0.51 (+0.27%) ▲|QCOM175.09+1.00 (+0.57%) ▲|RTX198.76-0.05 (-0.03%) ▼|SBUX100.83-1.19 (-1.16%) ▼|SCHW107.34+0.47 (+0.44%) ▲|SO88.21-0.78 (-0.88%) ▼|SPG206.38-3.25 (-1.55%) ▼|T25.10-0.51 (-1.97%) ▼|TMO606.16+3.14 (+0.52%) ▲|TMUS177.68-4.01 (-2.21%) ▼|TSLA368.98+0.82 (+0.22%) ▲|TXN261.45+2.53 (+0.98%) ▲|UBER71.71-1.42 (-1.94%) ▼|UNH392.19-8.65 (-2.16%) ▼|UNP284.77-3.68 (-1.28%) ▼|UPS99.34-1.15 (-1.14%) ▼|USB62.18-0.31 (-0.50%) ▼|V368.41-0.23 (-0.06%) ▼|VZ49.60-0.82 (-1.62%) ▼|WFC89.63+1.67 (+1.90%) ▲|WMT105.88-0.17 (-0.16%) ▼|XOM164.66+4.00 (+2.49%) ▲|
27.1 C
New York
Wednesday, September 9, 2026

Tag: brain

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals

Hemispherian Receives U.S. FDA Orphan Drug Designation for GLIX1 for the Treatment of Malignant Glioma

OSLO, Norway, July 1, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the U.S....

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application

EINDHOVEN, the Netherlands, July 01, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announced the submission of two major regulatory applications for its ARC-EX System. The Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) seeking clearance to expand its indication for home use. In parallel, ONWARD has filed an application with the notified body for CE Mark certification in accordance with the European Union Medical Device Regulation (MDR) to enable commercialization of the ARC-EX System in the EU. Completed in June, these submissions represent significant milestones as the Company advances its mission to bring breakthrough therapies to people with SCI around the world.

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities

SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced the closing of its underwritten public offering of 15,000,000 shares of its common stock and accompanying common warrants to purchase up to 16,766,666 shares of common stock at a public offering price of $3.00 per share and accompanying warrant, which includes common warrants to purchase up to 1,766,666 shares issued upon the partial exercise by the underwriters of their option to purchase additional shares of common stock and/or accompanying warrants. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, were $45.0 million.

Florida Chamber of Commerce Appoints John Doolittle to Lead Health Council; Florida Chamber Leadership Cabinet Launches Mental Wellness Institute to Improve Behavioral Health for...

TALLAHASSEE, Fla., June 30, 2025 /PRNewswire/ -- The Florida Chamber Leadership Cabinet on Safety, Health, and Sustainability—the Chamber's entity guiding statewide efforts to improve workplace...

Hisense Showcases AI Technology Strength with “AI YOUR LIFE” Message at FIFA Club World Cup 2025™

QINGDAO, China, June 30, 2025  /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, is showcasing its AI leadership at...

Java Brain Releases 2025 Research Update on Coffee-Based Neuroinflammation Trends and Cognitive Wellness Support

The 2025 update explores how evolving consumer interest in brain fog, coffee-enhanced wellness routines, and ingredient transparency is shaping the future of cognitive support.
The 2025 update explores how evolving consumer interest in brain fog, coffee-enhanced wellness routines, and ingredient transparency is shaping the future of cognitive support.

MGI ANNOUNCES PARTNERSHIP WITH NEGEDIA: ENHANCE GENOMIC SEQUENCING TECHNOLOGIES AT THE SERVICE OF SCIENTIFIC RESEARCH AND PRECISION MEDICINE IN ITALY

In the study of rare diseases and precision medicine, understanding gene expression in the spatial context of tissues is essential. High-throughput sequencing and STOmics technology will...

Prism Pain and Wellness Offering Novel Brain Stimulation to Treat Depression and Optimize Mental Health

ENGLEWOOD, Colo., June 26, 2025 /PRNewswire/ -- The pinnacle of medication-free wellness is now available for those struggling with depression, anxiety and mental fog....

Z Natural Foods Unveils Organic Cognitive Cacao & Coffee — a Next-Generation Fusion of Cacao, Matcha Green Tea, MCTs, Organic Coffee and Functional Mushrooms

WEST PALM BEACH, Fla., June 26, 2025 /PRNewswire/ -- Z Natural Foods today broadened its celebrated line of superfood blends with the debut of...

BioArctic: Professor Lars Lannfelt to receive the 2025 Hartwig Piepenbrock-DZNE Prize

STOCKHOLM, June 26, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that BioArctic's founder, Professor Lars Lannfelt, will receive the 2025...

Mind Vault Introduces Senior Cognitive Health Update: Brain Support Formula Highlights Age-Focused Innovation

Cognitive Wellness Announcement Highlights New Senior Brain Health Formulation with Scientifically Backed Ingredients
Cognitive Wellness Announcement Highlights New Senior Brain Health Formulation with Scientifically Backed Ingredients

Audifort Update Reveals Breakthrough Botanical Formulation for Hearing Health Support in 2025

Plant-Based Daily Formula Updated in 2025 to Support Holistic Hearing Wellness and Lifestyle Resilience
Plant-Based Daily Formula Updated in 2025 to Support Holistic Hearing Wellness and Lifestyle Resilience

Hyundai Hope on Wheels donates $250,000 to BC Children’s Hospital Foundation to support children facing cancer

Every year in B.C., approximately 130 children are diagnosed with cancer. As the province's only full-service acute-care hospital dedicated to children, BC Children's Hospital...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBrain